Baxter International, Inc.
One Baxter Parkway
Deerfield
Illinois
60015
United States
Tel: 847-948-2000
Fax: 847-948-3642
Website: http://www.baxter.com/
About Baxter International, Inc.
Baxter touches millions of lives every day. Our products and services are essential building blocks of healthcare.
You’ll find Baxter’s products and therapies on nearly every floor, in every department, in almost every hospital worldwide. You’ll find us in clinics and in the home. Patients and providers rely on Baxter for lifesaving renal and medical products, including intravenous (IV) solutions, systems and administrative sets, IV infusion parenteral nutrition, perioperative care, pharmacy devices and software, acute renal care, and home and in-center dialysis.
Our mission to save and sustain lives inspires our work and our commitment to expanding access to care, providing cost-effective healthcare solutions, delivering quality products and advancing innovations for the world.
Our commitment to our mission means we are there when patients and healthcare professionals need us, during the critical moments that matter most.
YEAR FOUNDED:
1931
LEADERSHIP:
CEO: José (Joe) E. Almeida
CMO: James R. Gavin III
CTO: Uma Chowdhry
CFO: Peter Hellman
PRODUCTS:
All Products
FOLLOW BAXTER INTERNATIONAL:
Tweets by Baxer International
962 articles about Baxter International, Inc.
-
Baxter Announces Health Canada Approval of Spectrum IQ Infusion System
7/25/2018
Designed with Exclusive New Features for Bi-Directional Electronic Medical Records Integration Including Auto-Programming and Auto-Documentation
-
Health Canada approves Baxter's 3-in-1 blood purification set for use in continuous renal replacement therapy and sepsis management protocols
7/10/2018
New indication to help remove excessive levels of cytokines and endotoxins in patients needing blood purification makes oXiris the first 3-in-1 set available in Canada
-
Baxter to Host Second Quarter 2018 Financial Results Conference Call for Investors
7/3/2018
Baxter International will host a conference call to discuss its second quarter 2018 financial results on Thursday, July 26, 2018, at 7:30 a.m. Central Time.
-
The medical device market was about $521.2 billion last year and is projected to hit $674.5 billion by 2022. Here’s a look at the top 10 medical device companies in the world this year.
-
Baxter Unveiled Updates to SHARESOURCE Remote Patient Management Platform for Home Dialysis Patients at ERA-EDTA 2018
5/30/2018
Baxter International Inc. announced the availability of two program updates for its SHARESOURCE remote patient management platform to support greater accessibility and efficiencies in remotely viewing patient data.
-
Baxter Supported Nine New Abstract Presentations at the 55th ERA-EDTA Congress That Further Demonstrate Value of HDx Therapy Enabled by THERANOVA
5/30/2018
Baxter International Inc. announced new data reinforcing that expanded hemodialysis (HDx) enabled by the THERANOVA dialyzer.
-
Baxter Highlights Business Strategies and Innovation at 2018 Investor Conference
5/21/2018
Company Increases Financial Guidance for 2020 and Provides Outlook for 2023
-
Baxter Announces U.S. FDA Clearance of New Spectrum IQ Infusion System
5/14/2018
Designed with Exclusive New Features for Bi-Directional Electronic Medical Records Integration Including Auto-Programming and Auto-Documentation
-
Baxter and the International Society of Nephrology Announce a Collaboration to Address Growing Prevalence of Kidney Disease
5/2/2018
Baxter International Inc. announced a partnership to advance chronic kidney disease (CKD) awareness and help improve access to therapy, particularly in low- and middle-income countries (LMIC) – commonly referenced as emerging markets – where the disease prevalence is growing the fastest.
-
Baxter Reports First-Quarter 2018 Results and Increases Financial Outlook for Full-Year 2018
4/26/2018
First-Quarter Revenue of $2.7 Billion Increased 8 Percent on a Reported Basis and 3 Percent on an Operational Basis
-
Baxter to Host First Quarter 2018 Financial Results Conference Call for Investors
4/4/2018
Baxter International, Inc. will host a conference call to discuss its first quarter 2018 financial results on Thursday, April 26, 2018, at 7:30 a.m. Central Daylight Time.
-
Baxter International Inc. to Host Webcast of Annual Meeting of Stockholders
4/2/2018
Baxter International, Inc. will host a webcast of its Annual Meeting of Stockholders on Tuesday, May 8, 2018 at 9:00 a.m. Central Time.
-
Shire stock prices jumped up to 26 percent on rumors that Takeda Pharmaceuticals was considering a buyout.
-
Baxter Completes Acquisition of RECOTHROM and PREVELEAK to Broaden Surgical Hemostat and Sealant Portfolio
3/19/2018
RECOTHROM Thrombin topical (Recombinant) is the first and only stand-alone recombinant thrombin and PREVELEAK Surgical Sealant is used in vascular reconstruction.
-
Baxter Declares Quarterly Dividend and Announces Expanded Share Repurchase Authorization
2/20/2018
Baxter International Inc. (NYSE:BAX) today announced a quarterly cash dividend and an expanded authorization for its share repurchase program.
-
Baxter to Present at the Raymond James & Associates 39th Annual Institutional Investors Conference
2/7/2018
Baxter will present at the Raymond James & Associates 39th Annual Institutional Investors Conference on Tuesday, March 6, 2018, in Orlando, Fla. Jay Saccaro, Baxter’s chief financial officer, is scheduled to present at 4:35 p.m. EST.
-
Baxter Reports 2017 Fourth-Quarter and Full-Year Results
2/1/2018
Baxter International, Inc. today reported results for the fourth quarter and full-year ended December 31, 2017, and provided its financial guidance for 2018.
-
Baxter Announces U.S. FDA Approval of Ready-to-Use Cardiovascular Medication Bivalirudin
1/22/2018
Baxter announced the U.S. Food and Drug Administration (FDA) approval of Bivalirudin in 0.9 percent Sodium Chloride Injection (bivalirudin).
-
Puma Hits a Huge Roadblock
1/17/2018
Despite some safety concerns such as severe diarrhea, the FDA approved Puma's breast cancer drug Nerlynx in July 2017. -
Baxter Launches Arisure Closed System Transfer Device to Help Prevent Hazardous Drug Exposure and Maintain Medication Sterility
1/11/2018
Baxter today announced a distribution agreement for the U.S. launch of the Arisure Closed System Transfer device.